TRF1 chemical inhibitors mimicked these effects in human GBM cells and also blocked tumor sphere formation [49], suggesting that TRF1 may be a promising target for developing an effective anti-cancer therapeutic strategy. Here, TERF1 is linked to glioblastoma.